• Alfuzosin Hydrochloride Assay Workflows

  2026-08-21

  A scenario-driven guide to using Alfuzosin Hydrochloride in cell viability, proliferation, and cytotoxicity workflows. It explains solvent selection, assay compatibility, data interpretation, and vendor reliability considerations for SKU A5173.

• Flavopiridol Workflows for CDK and ER-Stress Studies

  2026-08-20

  Flavopiridol (L868275) combines potent pan-CDK activity with flexible use in cell-cycle, apoptosis, transcription, and cancer research workflows. This guide shows how to connect CDK inhibition with the GRP78/ATF6/CHOP findings of an intestinal ER-stress study while preserving appropriate controls and interpretation.

• PP 1: Src Family Tyrosine Kinase Inhibitor

  2026-08-20

  PP 1 is a Src family tyrosine kinase inhibitor with reported nanomolar activity against Lck and Fyn. Its defined chemical profile and reported effects on Lyn, RET-linked transformation, tyrosine phosphorylation, and T-cell proliferation support controlled pathway studies rather than direct clinical translation.

• DiscoveryProbe Natural Product Library Plus Guide

  2026-08-19

  A practical, scenario-based guide to using DiscoveryProbe™ Natural Product Library Plus (Catalog No. L1039P) for reproducible cell viability, proliferation, cytotoxicity, and target-focused screening. It covers assay compatibility, dilution strategy, orthogonal validation, data interpretation, and vendor-selection criteria for SKU L1039P.

• PPP1R3G/PP1γ Activates RIPK1 Cell Death

  2026-08-19

  The reference study identifies PPP1R3G as a regulatory adaptor that recruits PP1γ to dephosphorylate RIPK1 and enable its kinase-dependent apoptotic and necroptotic functions. Its combination of sensitized CRISPR screening, genetic rescue, phosphorylation-site analysis, and mouse studies provides a mechanistic framework for understanding how TNF signaling switches from survival toward inflammatory cell death.

• Endogenous Melatonin in LPS-Activated Macrophages

  2026-08-18

  This study identifies an inducible melatonin feedback circuit in LPS-stimulated, M1-like macrophages. It shows that TLR4/TRIF-dependent IRF3 activity promotes Aanat transcription and endogenous melatonin production, which then restrains inflammatory polarization and delays apoptosis.

• STING agonist-1: From Signal to Assay Design

  2026-08-18

  STING agonist-1 enables controlled interrogation of innate immune signaling beyond a simple interferon readout. This article connects STING pathway activation in innate immunity with TRAF2–IRF4 biology, B-cell activation, and tertiary lymphoid structure research while emphasizing assay controls and interpretation.

• Fenofibrate Workflows for PPARα and YAP Research

  2026-08-17

  Build reproducible Fenofibrate experiments across lipid metabolism, liver biology, and cancer models with practical guidance on dosing, solubility, pathway validation, and assay controls. The workflow connects PPARα activation with YAP-dependent tissue responses while keeping cytotoxicity findings separate from mechanistic interpretation.

• SIS3 in TGF-β/SMAD3 Cancer Mechanism Studies

  2026-08-17

  SIS3 is a selective Smad3 inhibitor for testing how canonical TGF-β signaling drives transcription, invasion, and fibrosis-related phenotypes. This article translates super-enhancer and lung adenocarcinoma findings into rigorous assay decisions without overstating preclinical evidence.

• SIS3 (Smad3 Inhibitor) for Causal TGF-β Assays

  2026-08-16

  SIS3 is a selective Smad3 inhibitor for separating Smad3-dependent transcription from broader TGF-β responses. This guide presents practical workflows for fibrosis research, renal fibrosis models, diabetic nephropathy research, and mechanistic lung adenocarcinoma studies, with controls and troubleshooting built in.

• RAS/PI3K Mutations Sensitize Ovarian Cancer Cells

  2026-08-15

  The reference study identifies RAS/PI3K pathway mutations as a potential biomarker for sensitivity to the NAMPT inhibitor FK866 and to combined PARP–NAMPT inhibition in epithelial ovarian cancer. Its integrated genomic, metabolic, cellular, and mouse-model analyses connect pathway genotype with NAD depletion, oxidative stress, DNA damage, apoptosis, reduced tumor burden, and longer survival.

• Adamtsl3, MMP9, and Perineuronal Net Plasticity

  2026-08-15

  The reference study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal net integrity in parvalbumin-positive cortical interneurons. Its genetic and pharmacological experiments connect Adamtsl3 loss to MMP9 dysregulation, reduced Otx2 uptake, oxidative stress, and the reactivation of adult cortical plasticity, providing a mechanistic framework for schizophrenia-related extracellular-matrix biology.

• Carboplatin: DNA Synthesis Inhibitor in Cancer Research

  2026-08-14

  Carboplatin is a platinum-based DNA synthesis inhibitor used in preclinical oncology research to damage DNA and suppress tumor-cell proliferation. Its activity spans ovarian and lung cancer models, while recent evidence links IGF2BP3–FZD1/7 signaling with carboplatin resistance in triple-negative breast cancer.

• Solanesol: Practical Handling and QC Guide

  2026-08-13

  Solanesol (SKU B8776) is a hydrophobic polyisoprenoid alcohol for controlled biochemical workflows involving membrane-related processes, apoptosis research, DNA damage and repair studies, metabolic enzyme assays, and protease activity research. This guide addresses preparation, controls, storage, and troubleshooting; the compound is unsuitable for aqueous or ethanol-based systems and is not intended for diagnostic, clinical, or medical use.

• Verapamil HCl: From Calcium Blockade to Translation

  2026-08-13

  A translational guide to Verapamil HCl as an L-type calcium channel blocker, connecting calcium signaling, drug efflux, apoptosis, myeloma research, and inflammation models.

449 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page